Intrinsic Therapeutics, Inc. Announces First Barricaid ARD Implant

WOBURN, Mass.-- May 31, 2008 --Intrinsic Therapeutics, Inc., a privately held company, announced that Dr. Milorad Vilendecic from the University Hospital Dubrava, Zagreb, implanted the first Barricaid ARD (Anular Reconstruction Device) in May of this year. Dr. Vilendecic was very impressed with the speed and ease of implantation. Additional implantations have since occurred as part of a multicenter trial involving numerous surgeons who have made similar comments such as easy, quick and straight forward to use.

About Intrinsic Therapeutics
Intrinsic Therapeutics, Inc., based in Woburn, MA, is a medical device company focused on developing innovative therapies that address the spine market's many unmet clinical needs. The company's first product is a revolutionary spinal implant that is being developed to treat the most common causes of sciatica and low back pain.

For more information please contact:
Intrinsic Therapeutics
Scott LeBlanc, Director of Finance
(781) 932-0222
finance@intrinsic-therapeutics.com